As of Apr 29
| +0.01 / +0.14%|
The 8 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 11.00 and a low estimate of 4.50. The median estimate represents a +4.46% increase from the last price of 7.18.
The current consensus among 8 polled investment analysts is to Hold stock in ARIAD Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.